Elevance Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Elevance Health, Inc. on January 25, 2024, reporting an event that occurred on January 23, 2024. The filing pertains to a corporate action regarding shareholder dividends.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial figure disclosed is the declaration of a quarterly cash dividend of $1.63 per share.
Material Changes
The material event reported is the declaration of a quarterly cash dividend by the Audit Committee of the Board of Directors. No other material changes to financial position or operations are detailed in this specific filing.
Guidance, Outlook, and Management Commentary
This filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a procedural announcement regarding the dividend schedule.
Key Facts for Investor Verification
- Dividend Amount: $1.63 per share.
- Record Date: March 8, 2024.
- Payment Date: March 22, 2024.
- Declaring Body: Audit Committee of the Board of Directors.
- Stock Symbol: ELV (New York Stock Exchange).